Cargando…
Consequences and therapy of the metabolic acidosis of chronic kidney disease
Metabolic acidosis is common in patients with chronic kidney disease (CKD), particularly once the glomerular filtration rate (GFR) falls below 25 ml/min/1.73 m(2). It is usually mild to moderate in magnitude with the serum bicarbonate concentration ([HCO(3)(−)]) ranging from 12 to 23 mEq/l. Even so,...
Autores principales: | Kraut, Jeffrey A., Madias, Nicolaos E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991191/ https://www.ncbi.nlm.nih.gov/pubmed/20526632 http://dx.doi.org/10.1007/s00467-010-1564-4 |
Ejemplares similares
-
Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment
por: Kim, Hyo Jin
Publicado: (2021) -
Secondary Response to Chronic Respiratory Acidosis in Humans: A Prospective Study
por: González, Silvia B., et al.
Publicado: (2018) -
Metabolic acidosis and the progression of chronic kidney disease
por: Chen, Wei, et al.
Publicado: (2014) -
Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease
por: Siener, Roswitha
Publicado: (2018) -
Treatment of acute non-anion gap metabolic acidosis
por: Kraut, Jeffrey A., et al.
Publicado: (2015)